Jenny Sprooten

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity.

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity.

Journal: Molecular oncology

Published: December 20, 2025

Trial watch: anticancer vaccination with dendritic cells.

Trial watch: anticancer vaccination with dendritic cells.

Journal: Oncoimmunology

Published: October 14, 2024

Next-generation DC vaccines with an immunogenic trajectory against cancer: therapeutic opportunities vs. resistance mechanisms.

Next-generation DC vaccines with an immunogenic trajectory against cancer: therapeutic opportunities vs. resistance mechanisms.

Journal: Genes and immunity

Published: August 27, 2024

Targeting conserved TIM3+VISTA+ tumor-associated macrophages overcomes resistance to cancer immunotherapy.

Targeting conserved TIM3+VISTA+ tumor-associated macrophages overcomes resistance to cancer immunotherapy.

Journal: Science advances

Published: July 19, 2024

Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.

Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.

Journal: Nature medicine

Published: July 15, 2024

A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.

A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.

Journal: Nature medicine

Published: September 01, 2023

The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy.

The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy.

Journal: Immunological reviews

Published: July 30, 2023

Trial watch: chemotherapy-induced immunogenic cell death in oncology.

Trial watch: chemotherapy-induced immunogenic cell death in oncology.

Journal: Oncoimmunology

Published: June 07, 2023

Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.

Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.

Journal: Science translational medicine

Published: April 12, 2023

Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer.

Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer.

Journal: Cell discovery

Published: March 22, 2023

Publisher Correction: Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy.

Publisher Correction: Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy.

Journal: Genes and immunity

Published: December 01, 2022

The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.

The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.

Journal: Cells

Published: October 29, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026